Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Silo Pharma, Inc.Financial_Report.xls
EX-31.2 - CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT - Silo Pharma, Inc.f10q0911ex31ii_goldswap.htm
EX-32.2 - CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT - Silo Pharma, Inc.f10q0911ex32ii_goldswap.htm
10-Q - QUARTERLY REPORT - Silo Pharma, Inc.f10q0911_goldswap.htm
EX-31.1 - CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT - Silo Pharma, Inc.f10q0911ex31i_goldswap.htm
EXHIBIT 32.1
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
 
The undersigned, Melvin Schlossberg, the President, Chief Executive Officer, Chairman and Director of Gold Swap Inc. (the “Company”), certifies, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2011 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in that Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
Dated: November 10, 2011
 
       
 
By:
/s/ Melvin Schlossberg  
  Name: Melvin Schlossberg  
  Title: President, Chief Executive Officer, Secretary and Director (Principal Executive Officer)